|
autoimmune disease of cardiovascular system
|
DOID_0060051 |
[An autoimmune hypersensitivity disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the cardiovascular system.] |
|
Nucleic Acid Synthesis Inhibitor
|
NCIT_C1661 |
[A pharmacological agent that inhibits DNA replication or RNA synthesis.] |
|
mitigation of host immune response by virus
|
GO_0030683 |
[A process by which a virus avoids the effects of the host organism's immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction.] |
|
modulation by virus of host process
|
GO_0019048 |
[The process in which a virus effects a change in the structure or processes of its host organism.] |
|
viral process
|
GO_0016032 |
[A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.] |
|
thiazolidinediones
|
CHEBI_50990 |
[A thiadiazolidine in which the 1,3-thiazolidine ring is substituted by two oxo groups.] |
|
C1QBP
|
OGG_3000000708 |
|
|
actin cytoskeleton reorganization
|
GO_0031532 |
[A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins.] |
|
cell cycle G1/S phase transition
|
GO_0044843 |
[The cell cycle process by which a cell in G1 phase commits to S phase.] |
|
oxidative phosphorylation
|
GO_0006119 |
[The phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis.] |
|
ATP metabolic process
|
GO_0046034 |
[The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator.] |
|
blood lymphocyte count
|
CMO_0000031 |
|
|
cell measurement
|
CMO_0000227 |
|
|
Abnormality of metabolism/homeostasis
|
HP_0001939 |
[Disorders of metabolism and homeostasis] |
|
Phenotypic abnormality
|
HP_0000118 |
[A phenotypic abnormality.] |
|
regulation of cellular protein catabolic process
|
GO_1903362 |
[Any process that modulates the frequency, rate or extent of cellular protein catabolic process.] |
|
regulation of protein catabolic process
|
GO_0042176 |
[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.] |
|
positive regulation of cellular protein catabolic process
|
GO_1903364 |
[Any process that activates or increases the frequency, rate or extent of cellular protein catabolic process.] |
|
positive regulation of cellular catabolic process
|
GO_0031331 |
[Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells.] |
|
positive regulation of protein catabolic process
|
GO_0045732 |
[Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.] |